Financial News
Biogen Idec (NQ: BIIB )
226.63
+0.23
(+0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Headline News about Biogen Idec
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via Benzinga
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://cdn.benzinga.com/files/images/story/2024/fed-chart-shutter3.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Eli-Lilly_4.jpeg?width=1200&height=800&fit=crop)
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
March 08, 2024
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
A Closer Look at 21 Analyst Recommendations For Biogen
March 05, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Biogen Unusual Options Activity
February 29, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-03-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/BIIB_3.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://g.foolcdn.com/editorial/images/767026/scientist-works-at-lab-bench.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Wall-Street_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Peering Into Biogen's Recent Short Interest
February 19, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://cdn.benzinga.com/files/images/story/2024/BIIB_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/14/citigroup_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Breaking Down Biogen: 8 Analysts Share Their Views
February 13, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-biogen-05-shutt.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
Biogen (BIIB) Q4 2023 Earnings Call Transcript
February 13, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/images/story/2024/wall-street-storm-shutter3.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/BIIB_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/data-charts_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Looking At Biogen's Recent Unusual Options Activity
February 12, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/millionaire-stocks-to-buy-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/AApharma-1.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.